Avenue Therapeutics, Inc. (ATXI)
0.19
+0.01
(+5.56%)
USD |
OTCM |
Feb 27, 16:00
Avenue Therapeutics Free Cash Flow : -1.743M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Fortress Biotech, Inc. | -30.14M |
| ACADIA Pharmaceuticals, Inc. | 6.308M |
| Alnylam Pharmaceuticals, Inc. | 465.38M |
| Savara, Inc. | -99.27M |
| BioMarin Pharmaceutical, Inc. | 717.02M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 0.383M |
| Free Cash Flow Per Share (Quarterly) | 0.1203 |
| Free Cash Flow to Equity (Quarterly) | 0.383M |
| Free Cash Flow to Firm (Quarterly) | 0.383M |
| Free Cash Flow Yield | -320.6% |